Glutamic acid

Treatment of epilepsy, mainly small seizures with equivalents, somatogenic, involutional, intoxicating psychoses, reactive states with depression, exhaustion; in case of mental retardation in children, Down’s disease, cerebral palsy, poliomyelitis (acute and convalescent periods), progressive myopathy, to eliminate and prevent neurotoxic effects that may occur when using isoniazid and other isonicotinic acid hydrazide products.